Alkermes plc Appoints Mark Namchuk, Ph.D., As Senior Vice President Of Research, Pharmaceutical And Nonclinical Development

Alkermes plc (NASDAQ: ALKS) today announced that it has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline. He will serve on the executive management team of Alkermes and report to Elliot Ehrich, M.D., Senior Vice President of Research & Development and Chief Medical Officer.

Help employers find you! Check out all the jobs and post your resume.